Cargando…

Limited Utility of Plasma M30 in Discriminating Non-Alcoholic Steatohepatitis from Steatosis – A Comparison with Routine Biochemical Markers

INTRODUCTION: The utility of Cytokeratin-18 fragment, namely CK18Asp396 (M30), for the diagnosis of non-alcoholic steatohepatitis (NASH) is currently uncertain. We aimed to provide further data in this area among multi-ethnic Asian subjects with NAFLD. MATERIALS AND METHODS: The accuracy of M30 for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Wah-Kheong, Sthaneshwar, Pavai, Nik Mustapha, Nik Raihan, Mahadeva, Sanjiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153577/ https://www.ncbi.nlm.nih.gov/pubmed/25184298 http://dx.doi.org/10.1371/journal.pone.0105903

Ejemplares similares

Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis
por: Kamarajah, Sivesh K, et al.
Publicado: (2019)

Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease
por: Lai, Lee-Lee, et al.
Publicado: (2017)

Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease
por: Zain, Shamsul Mohd, et al.
Publicado: (2015)

Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy
por: Chan, Wah-Loong, et al.
Publicado: (2023)

Calculated parameters for the diagnosis of Wilson disease
por: Zulkufli, Nada Syazana, et al.
Publicado: (2022)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Association between non‐alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community
por: Tan, Eugene Choon‐Li, et al.
Publicado: (2018)

Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
por: Chan, Wah Loong, et al.
Publicado: (2023)

Epidemiological differences of common liver conditions between Asia and the West
por: Jayaraman, Thevaraajan, et al.
Publicado: (2019)

Use of simple scoring systems for a public health approach in the management of non‐alcoholic fatty liver disease patients
por: Zain, Shamsul Mohd, et al.
Publicado: (2020)

Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease
por: Chan, Wah‐Kheong, et al.
Publicado: (2022)

Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy
por: Chan, Wah-Kheong, et al.
Publicado: (2011)

Sarcopoterium spinosum Inhibited the Development of Non-Alcoholic Steatosis and Steatohepatitis in Mice
por: Wollman, Ayala, et al.
Publicado: (2019)

CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
por: Ju, Linling, et al.
Publicado: (2020)

Steatosis and Steatohepatitis: Complex Disorders
por: Bettermann, Kira, et al.
Publicado: (2014)

Improvement in polycythaemia vera after parathyroidectomy for primary hyperparathyroidism
por: Sthaneshwar, Pavai, et al.
Publicado: (2022)

Clinicopathological Comparison of Adenocarcinoma of Cervix and Endometrium Using Cell Cycle Markers: P16ink4a, P21waf1, and p27Kip1 on 132 Cancers
por: Marican Abu Backer, Farveen, et al.
Publicado: (2011)

Acquiring new complex endoscopic skills: Experience from the development of peroral endoscopic myotomy (POEM) in Malaysia
por: Ho, Shiaw Hooi, et al.
Publicado: (2021)

Refractory Helicobacter pylori treatment in resource‐limited settings
por: Mahadeva, Sanjiv
Publicado: (2023)

Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story
por: Cataldi, Mauro, et al.
Publicado: (2021)

The Role of Lipid Profile as an Independent Predictor of Non-alcoholic Steatosis and Steatohepatitis in Morbidly Obese Patients
por: Ganjooei, Narges Ashraf, et al.
Publicado: (2021)

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study
por: Zhang, Huai, et al.
Publicado: (2023)

Telemedicine in routine gastroenterology practice: A boost during the COVID‐19 pandemic
por: Leow, Alex H‐R, et al.
Publicado: (2021)

Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
por: Ganbold, Munkhzul, et al.
Publicado: (2019)

Similar Reduction of Cholesterol-Adjusted Vitamin E Serum Levels in Simple Steatosis and Non-Alcoholic Steatohepatitis
por: Pastori, Daniele, et al.
Publicado: (2015)

β-Hydroxyphosphocarnitine modifies fibrosis, steatosis and improves liver function in non-alcoholic steatohepatitis induced in rats
por: Sánchez-Quevedo, Janet, et al.
Publicado: (2022)

New discriminant score to predict the fibrotic stage of non-alcoholic steatohepatitis in Japan
por: Kawamura, Yusuke, et al.
Publicado: (2015)

Lycium barbarum polysaccharides therapeutically improve hepatic functions in non-alcoholic steatohepatitis rats and cellular steatosis model
por: Xiao, Jia, et al.
Publicado: (2014)

Saroglitazar improved hepatic steatosis and fibrosis by modulating inflammatory cytokines and adiponectin in an animal model of non-alcoholic steatohepatitis
por: Akbari, Rasoul, et al.
Publicado: (2021)

Differential Intrahepatic Phospholipid Zonation in Simple Steatosis and Nonalcoholic Steatohepatitis
por: Wattacheril, Julia, et al.
Publicado: (2013)

Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis
por: Vulf, Maria, et al.
Publicado: (2021)

Plasma Oxylipin Profile Discriminates Ethnicities in Subjects with Non-Alcoholic Steatohepatitis: An Exploratory Analysis
por: Mazi, Tagreed A., et al.
Publicado: (2022)

Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
por: Ting, Yi-Wen, et al.
Publicado: (2021)

Arazyme Suppresses Hepatic Steatosis and Steatohepatitis in Diet-Induced Non-Alcoholic Fatty Liver Disease-Like Mouse Model
por: Li, Hua, et al.
Publicado: (2019)

Spatial expression of glucagon-like peptide 1 receptor and caveolin-1 in hepatocytes with macrovesicular steatosis in non-alcoholic steatohepatitis
por: Yokomori, Hiroaki, et al.
Publicado: (2020)

Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model
por: Hamada, Shintaro, et al.
Publicado: (2022)

The Value of Routine Biochemical Tests in Discriminating Between Malignant and Benign Pancreatic Tumours
por: Athlin, L., et al.
Publicado: (1991)

Genome-Wide Analysis of Copy Number Variation Identifies Candidate Gene Loci Associated with the Progression of Non-Alcoholic Fatty Liver Disease
por: Zain, Shamsul Mohd, et al.
Publicado: (2014)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lvc793smut8bnqtfh95mk5hgv6